Alpha Fusion
Developer of alpha nuclear medicine therapy using astatine intended to provide innovative cancer treatment. The company engaged in drug discovery and business development of low-molecular-weight and a...
Valuation
$20.7M
Market implied
Share Price
N/A
Total Raised
$11.9M
Last Round
N/A